Fampridine [Design Issues]

posted by MaggieSantos – Portugal, 2017-09-20 15:05 (2698 d 03:44 ago) – Posting: # 17821
Views: 5,344

Good morning,

We have been asked to perform a BE study on Fampridine.

I would like to confirm two informations. Does Fampridine is considered a NTI drug for EMA?

Considering a CI limit of 90-111% whats the recomende sample size for fampridine.

Do you know any good and free calculation site for BE?

Kind Regards

mMrgarida Barreto

Complete thread:

UA Flag
Activity
 Admin contact
23,376 posts in 4,912 threads, 1,667 registered users;
240 visitors (0 registered, 240 guests [including 15 identified bots]).
Forum time: 17:49 CET (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5